MNTA - Since NVS reported $259M in 3Q11 sales of generic Lovenox, we now know that NVS had a 59% market share during 3Q11. Might that be part of the reason for the AG? ? Even with higher GM mL is making meaningfully more cash than branded after COGS is removed.